Analysis of clinical distribution and drug resistance of <i>Escherichia coli </i> and <i>Klebsiella pneumoniae</i> in a hospital of Nanjing from 2020 to 2022

Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 5

Abstract

<b>Objective</b> The clinical distribution and drug resistance of <i>Escherichia coli </i> and<i>Klebsiella pneumoniae </i> in a hospital of Nanjing from 2020 to 2022 were analyzed in order to provide the basis for clinical rational use of antibiotics. <b>Methods</b> The distribution and drug resistance of <i>Escherichia coli </i> and <i>Klebsiella pneumoniae </i> specimens in Zhongda Hospital Southeast University from 2020 to 2022 were retrospectively analyzed.<b>Results</b> A total of 3 507, 4 323 and 4 806 pathogenic bacteria were detected from 2020 to 2022. There were 616, 748 and 840 strains of <i>Escherichia coli </i>, and 456, 631 and 757 strains of <i>Klebsiella pneumoniae </i>, with the total 3-year detection rate of 17.4% and 14.6%. There was a statistically significant difference in the constituent ratio of pathogenic bacteria between 2020 and 2022 (P<0.01). From 2020 to 2022, the top three samples of pathogenic bacteria were sputum, blood and urine. From 2020 to 2022, the drug resistance rates of <i>Escherichia coli </i> to cefepime, ceftriaxone, cefazolin, gentamicin, ciprofloxacin, levofloxacin and compound trimethoprim were significantly different (P<0.01). The drug resistance rates of <i>Klebsiella pneumoniae </i> to imipenem, ertapenem, cefepime, ceftriaxone, cefoperazone sulbactam, cefazolin, cefoxitin, piperacillin tazobactam, ampicillin, amikacin, gentamicin, levofloxacin, nitrofurantoin and compound trimethoprim were significantly different (P<0.01).<b>Conclusion</b> The average detection rate of <i>Escherichia coli </i>and <i>Klebsiella pneumoniae </i> was more than 30% in 2020—2022. The resistance of <i>Escherichia coli </i>and <i>Klebsiella pneumoniae </i> to various antibacterial drugs is statistically different. The clinically targeted drugs need to be selected in strict accordance with the drug sensitivity results.

Authors and Affiliations

ZHANG Hongfang, LU Jin, CHEN Zhicheng, HU Jimei, KONG Qingfang

Keywords

Related Articles

Development of navigation assisted minimally invasive spine surgery

In recent years, minimally invasive spine surgery (MISS) has gradually become a feasible, highly effective and popular method for the treatment of various spinal diseases. Compared to traditional open surgery, MISS has m...

Research progress of esketamine and postoperative delirium

Postoperative delirium (POD) is a common complication in elderly patients after surgery, significantly affecting prognosis and increasing mortality rates. The underlying mechanisms of POD remain unclear, with diverse ris...

Risk factors, pathogenic bacteria and drug sensitivities of pancreatic fistula combined with abdominal infection after pancreaticoduodenectomy

Objective To investigate the risk factors for pancreatic fistula combined with abdominal infection after pancreaticoduodenectomy, and to analyze the composition of pathogens and their drug sensitivity. Methods A retros...

Effects of nerve block in different areas on opiate dosage and stress response in patients undergoing thoracoscopic radical resection of lung cancer

<b>Objective</b> To explore the effects of ultrasound-guided serratus anterior plane block (SAPB) and thoracic paravertebral block (TPVB) on opiate dosage and stress response in patients undergoing thoracoscopic radical...

Bronchoscopic lavage-assisted treatment of Mycoplasma pneumonia in children:a Meta-analysis of randomized controlled trials

"Objective To systematically evaluate the clinical efficacy of bronchoscopic lavage-assisted treatment of Mycoplasma pneumonia (MP) in children, providing references for clinical treatment. Methods China National Knowl...

Download PDF file
  • EP ID EP736345
  • DOI 10.13429/j.cnki.cjcr.2024.05.025
  • Views 40
  • Downloads 0

How To Cite

ZHANG Hongfang, LU Jin, CHEN Zhicheng, HU Jimei, KONG Qingfang (2024). Analysis of clinical distribution and drug resistance of <i>Escherichia coli </i> and <i>Klebsiella pneumoniae</i> in a hospital of Nanjing from 2020 to 2022. Chinese Journal of Clinical Research, 37(5), -. https://europub.co.uk/articles/-A-736345